No Data
No Data
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $78
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED), Avidity Biosciences (RNA) and Veeva Systems (VEEV)
Buy Rating Affirmed for Globus Medical Despite FDA Warning: Manageable Regulatory Challenges Ahead
Trending Stocks Today | Greenland Technologies Surges 53.7% Post-Market
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $93
No Data